Control placebo
Sponsors
Seoul National University Hospital, Probi AB, Biosearch S.A., Larkin Community Hospital, Yooyoung Pharmaceutical Co., Ltd.
Conditions
Androgenetic AlopeciaCovid19Digestive HealthDyslipidemiasEndurance ExerciseEnergyExercise PerformanceHepatic Steatosis
Phase 2
The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss
CompletedNCT01548066
Start: 2011-09-30End: 2012-06-30Updated: 2012-10-08
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
CompletedNCT02108119
Start: 2014-05-02End: 2015-11-30Updated: 2017-06-16
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
CompletedNCT03167593
Start: 2015-10-01End: 2016-04-30Updated: 2017-05-30
A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease
CompletedNCT06442137
Start: 2024-07-17End: 2025-01-02Updated: 2025-04-03
A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease
Not yet recruitingNCT07320456
Start: 2025-12-29End: 2026-07-31Target: 80Updated: 2026-01-06
Phase 3
Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients
WithdrawnNCT04854486
Start: 2021-12-16End: 2022-11-16Updated: 2023-10-16
Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
NCT04858308
Start: 2021-01-29End: 2022-01-31Target: 554Updated: 2021-04-26
Unknown Phase
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
RecruitingNCT06946017
Start: 2025-03-31End: 2027-06-30Target: 114Updated: 2025-04-27
The Effects of Liquid IV's Multi-Ingredient Recovery Supplement on Muscle Recovery Following Exercise
Not yet recruitingNCT07224867
Start: 2026-05-01End: 2026-10-01Target: 30Updated: 2026-04-03
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
CompletedNCT07225608
Start: 2025-12-01End: 2026-02-09Updated: 2026-03-06
Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection
Not yet recruitingNCT07397910
Start: 2026-02-23End: 2026-08-03Target: 40Updated: 2026-02-09